Combined modality treatment in the management of high-risk prostate cancer.
作者： Richard G Stock , Oren Cahlon , Jamie A Cesaretti , Marisa A Kollmeier , Nelson N Stone
DOI: 10.1016/J.IJROBP.2004.01.023
关键词:
摘要: … High-risk prostate cancer has remained a therapeutic … the results for this subset of prostate cancer patients. Many of these new … Advances in RT for high-risk prostate cancer have used …
elsevier.com
sci-hub.se 参考文章(45)
Joseph G. Trapasso, Jean B. Dekernion, Robert B. Smith, Fred Dorey, The Incidence and Significance of Detectable Levels of Serum Prostate Specific Antigen After Radical Prostatectomy Journal of Urology. ,vol. 152, pp. 1821- 1825 ,(1994) , 10.1016/S0022-5347(17)32394-7
Edward C. Jones, Resection Margin Status in Radical Retropubic Prostatectomy Specimens: Relationship to Type of Operation, Tumor Size, Tumor Grade and Local Tumor Extension Journal of Urology. ,vol. 144, pp. 89- 93 ,(1990) , 10.1016/S0022-5347(17)39376-X
Lindsey A. Kerr, Stuart B. Bauer, David R. Staskin, Abnormal Detrusor Function Precipitating Hydronephrosis Identified by Extended Voiding Cystometry Journal of Urology. ,vol. 152, pp. 89- 92 ,(1994) , 10.1016/S0022-5347(17)32824-0
Mark A. Rosen, Lawrence Goldstone, Stephen Lapin, Thomas Wheeler, Peter T. Scardino, Frequency and Location of Extracapsular Extensionand Positive Surgical Margins in Radical Prostatectomy Specimens The Journal of Urology. ,vol. 148, pp. 331- 337 ,(1992) , 10.1016/S0022-5347(17)36587-4
A.L. Zietman, J.J. Coen, W.U. Shipley, C.G. Willett, J.T. Efird, Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome The Journal of Urology. ,vol. 151, pp. 640- 645 ,(1994) , 10.1016/S0022-5347(17)35036-X
Richard G. Stock, Nelson N. Stone, Johnny Kao, Christopher Iannuzzi, Pamela Unger, The effect of disease and treatment-related factors on biopsy results after prostate brachytherapy: implications for treatment optimization. Cancer. ,vol. 89, pp. 1829- 1834 ,(2000) , 10.1002/1097-0142(20001015)89:8<1829::AID-CNCR25>3.0.CO;2-9
M V Pilepich, R Caplan, R W Byhardt, C A Lawton, M J Gallagher, J B Mesic, G E Hanks, C T Coughlin, A Porter, W U Shipley, D Grignon, Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31. Journal of Clinical Oncology. ,vol. 15, pp. 1013- 1021 ,(1997) , 10.1200/JCO.1997.15.3.1013
Richard G. Stock, Nelson N. Stone, Christopher Ianuzzi, Pamela Unger, Seminal vesicle biopsy and laparoscopic pelvic lymph node dissection: implications for patient selection in the radiotherapeutic management of prostate cancer International Journal of Radiation Oncology Biology Physics. ,vol. 33, pp. 815- 821 ,(1994) , 10.1016/0360-3016(95)02007-4
Deborah A. Kuban, Anas M. El-Mahdi, Paul F. Schellhammer, Prostate-specific antigen for pretreatment prediction and posttreatment evaluation of outcome after definitive irradiation for prostate cancer International Journal of Radiation Oncology Biology Physics. ,vol. 32, pp. 307- 316 ,(1995) , 10.1016/0360-3016(95)00137-N
Gerald E. Hanks, W.Robert Lee, Alexandra L. Hanlon, Margie Hunt, Edward Kaplan, Barry E. Epstein, Benjamin Movsas, Timothy E. Schultheiss, Conformal technique dose escalation for prostate cancer: Biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen ≥10 ng/ml International Journal of Radiation Oncology Biology Physics. ,vol. 35, pp. 861- 868 ,(1996) , 10.1016/0360-3016(96)00207-6